| Literature DB >> 22166061 |
Zhiqun Tang1, Lihua Zhang, Amrita K Cheema, Habtom W Ressom.
Abstract
BACKGROUND: In proteomics studies, liquid chromatography coupled to mass spectrometry (LC-MS) has proven to be a powerful technology to investigate differential expression of proteins/peptides that are characterized by their peak intensities, mass-to-charge ratio (m/z), and retention time (RT). The variable complexity of peptide mixtures and occasional drifts lead to substantial variations in m/z and RT dimensions. Thus, label-free differential protein expression studies by LC-MS technology require alignment with respect to both RT and m/z to ensure that same proteins/peptides are compared from multiple runs.Entities:
Year: 2011 PMID: 22166061 PMCID: PMC3289071 DOI: 10.1186/1477-5956-9-S1-S10
Source DB: PubMed Journal: Proteome Sci ISSN: 1477-5956 Impact factor: 2.480
The CV and correlation of our in-house LC-MALDI-TOF dataset before and after alignment. The result of the best performing method is in boldface.
| After alignment | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Original | Our method using three dimensions ( | Our method using two dimensions ( | Podwojski’s method (hierarchical clustering and linear regression) | Podwojski’s method (hierarchical clustering and loess) | ||||||
| Group | CV | Corr | CV | Corr | CV | Corr | CV | Corr | CV | Corr |
| 1 | 32 | 0.31 | 31 | 0.71 | 26 | 0.68 | 29 | 0.79 | ||
| 2 | 30 | 0.39 | 26 | 0.82 | 19 | 0.86 | 29 | 0.89 | ||
| 3 | 28 | 0.45 | 31 | 0.7 | 22 | 0.67 | 30 | 0.71 | ||
| 4 | 27 | 0.5 | 0.93 | 26 | 0.83 | 25 | 0.94 | 24 | ||
| 5 | 33 | 0.36 | 31 | 0.75 | 26 | 0.77 | 28 | |||
CV=coefficient of variation (%); Corr=Pearson correlation coefficient; Group 1=samples without spike-in peptides; Group 2=samples with spike-in peptides; Group 3=Groups 1 and 2 combined.
Figure 1The TICs of LC-MALDI-TOF maps of 12 serum samples from our in-house dataset before (Panel A) and after alignment (Panel B). x axis is the fraction number from 1 to 100 and y axis is the TIC values calculated from m/z between 1510 to 1515 Da. Runs 1 to 6 were obtained from the serum samples without spike-in peptides and Runs 7 to 12 were obtained from serum samples with four spike-in peptides.
The m/z and RT values of the spike-in peptides in our in-house LC-MALDI-TOF dataset before and after alignment. The ranges of RT before alignment were obtained from the MALDI-TOF-TOF spectra of the samples with spike-in peptides.
| Original (before alignment) | After alignment | |||
|---|---|---|---|---|
| Spiked-in peptides | ||||
| Angiotensin | 1296.7 | 41-44 | 1296.03 | 52 |
| Glu1-Fibrinopeptide B | 1570.7 | 31-34 | 1570.65 | 35 |
| ACTH 1-17 fragment | 2093.1 | 22-24 | 2093.97 | 30 |
| ACTH 18–39 fragment | 2465.2 | 55-60 | 2465.13 | 63 |
Figure 2The TICs of LC-MALDI-TOF maps of 24 urine samples from Benkali’s dataset before (Panel A) and after (Panel B) alignment. x axis is the fraction number from 100 to 358 and y axis is the TIC values calculated from m/z 2000 to 2500 Da. Runs 1 to 6 were obtained from urine samples without spike-in peptides. Runs 7 to 12 were obtained from urine samples with 0.25X spike-in peptides. Runs 13-18 were obtained from samples with 0.5X spike-in peptides. Runs 19-24 were obtained from samples with 1X spike-in peptides.
The CV and correlation of the Benkali’s LC-MALDI-TOF dataset before and after alignment. The result of the best performing method is in boldface.
| After alignment | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Original | Our method using three dimensions ( | Our method using two dimensions ( | Podwojski’s method (hierarchical clustering and linear regression) | Podwojski’s method (hierarchical clustering and loess) | ||||||
| Group | CV | Corr | CV | Corr | CV | Corr | CV | Corr | CV | Corr |
| 1 | 32 | 0.31 | 31 | 0.71 | 26 | 0.68 | 29 | 0.79 | ||
| 2 | 30 | 0.39 | 26 | 0.82 | 19 | 0.86 | 29 | 0.89 | ||
| 3 | 28 | 0.45 | 31 | 0.7 | 22 | 0.67 | 30 | 0.71 | ||
| 4 | 27 | 0.5 | 0.93 | 26 | 0.83 | 25 | 0.94 | 24 | ||
| 5 | 33 | 0.36 | 31 | 0.75 | 26 | 0.77 | 28 | |||
CV=coefficients of variation (%); Corr=Pearson correlation coefficient; Group 1=samples without spike-in peptides; Group 2=samples with 0.25X spike-in peptides; group 3: samples with 0.5X spike-in peptides; group 4: samples with 1X spike-in peptides; Group 5: Group 1-4 combined.